You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1980510 |
---|---|
Category | Antibodies |
Description | Brazikumab (AMG 139) is a humanized antibody targeting IL-23 by binding to the P19 subunit. It is a selective IL23p19 antagonist and can be used in Crohn's disease research. |
Clonality | Monoclonal |
CAS Number | 1610353-18-8 |
Concentration | 5.98 mg/mL |
Purity | 95.00% |
Conjugation | Unconjugated |
Target | Brazikumab |
Biological Activity | Brazikumab (AMG 139), a human IgG2 monoclonal antibody, selectively targets the p19 subunit of IL-23 with a dissociation constant (K D) of 0.138 nM, indicating high affinity for human IL-23. It is employed in Crohn's disease research [1]. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |